Posted November 17, 2017
Many in Congress do, according to a letter nearly 80 representatives just sent to the FDA, USDA, and EPA. Action Alert! The letter, presumably inspired by big corporate donors, calls for the agencies to provide a “consistent, appropriate” approach to the regulation of biotechnology. On the one hand, the FDA has proposed to regulate any animal intentionally altered using gene editing techniques as an animal drug; on the other hand, the USDA has recently proposed to make it easier to bring “low-risk” genetically engineered plants to market. Read more.